UCLParnters

What UCLParnters does

UCLPartners is a UK health innovation company, founded in 2009 and headquartered in London, that operates as a designated Academic Health Science Network (AHSN) within England's 15-member Health Innovation Network. The company is anchored by a consortium of founding NHS trusts (Barts Health, Royal Free, Moorfields, Royal London, Great Ormond Street), universities (UCL, Queen Mary, Imperial, City St George's), and is now chaired by Dorothy Chou, formerly of Google DeepMind. Its remit spans the full innovation lifecycle: futures thinking and forecasting, clinical innovation creation within member trusts, implementation support, NHS-wide scaling via programmes like the NHS Innovation Accelerator, and evaluation/insights.

The product portfolio centres on the Proactive Care Frameworks (systematic risk stratification and self-management support across six long-term conditions: hypertension, Type 2 diabetes, cholesterol, atrial fibrillation, asthma, COPD), with companion EMIS and SystmOne search tools. Adjacent digital products include the Living With Covid Recovery rehabilitation app (deployed across 30 clinics in 20 NHS trusts, supported by £780k+ from NIHR), the Bedside Learning Coordinator web app (built with Telesoftas), and the recently launched PuntoTest and PuntoCare AI-enabled dementia apps. Programmes such as the 12-month Innovation Fellowship and the national NHS Innovation Accelerator complement these product offerings, alongside cross-sector initiatives including the Climate Collaborative and partnerships with the Alzheimer's Society and the Association of Anaesthetists.

The business model is principally commission and grant-funded: most income derives from public-sector and not-for-profit organisations, including NHS England commissions, NIHR research grants, and government-funded programmes. A secondary stream of revenue comes from industry joint working agreements structured under the Health Innovation Network's ethical framework. UCLPartners serves four primary customer groups: founders and clinical innovators; NHS trusts, hospitals, primary care networks and integrated care systems; funders and investors; and patients, carers and communities. The company is incorporated in England and Wales (company number 06878225) with 51-100 employees, and there is no evidence of external venture or private equity ownership.

Name

UCLParnters

Legal name

UCLPartners

Website

https://uclpartners.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

51–100 employees

Short description

UCLPartners is a UK health innovation company that helps NHS trusts, universities, and industry partners translate research into real-world clinical impact through proactive care frameworks, digital health tools, AI deployments, and national scaling programmes such as the NHS Innovation Accelerator.

Ownership category

akta.pro rank

Product category

Health Innovation Services

NAICS

General Medical and Surgical Hospitals (6221)

SIC

Services-Hospitals (8060)

akta.pro primary industry

Academic Medical Centers (AMCs) & Teaching Hospitals (HLAFAAAA)

akta.pro secondary industries

Public Research Universities with Academic Medical Centers (AMCs) (EDAHAAAC), Hospital-at-Home & Acute Virtual Care Platforms (HLALABAC)

Keywords

• Health innovation services
• NHS implementation support
• Clinical research partnerships
• Care pathway redesign
• Digital health programmes

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Public Sector Funding: Most income comes from public sector and not-for-profit organisations including NHS England commissions, NIHR research grants, and government-funded programmes.
2. Industry Partnerships: Joint working agreements with commercial organisations where this supports specific programmes of work. Part of the Health Innovation Network following ethical principles for working with industry.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

UCLPartners is a health innovation company that accelerates the development, evaluation, and adoption of healthcare innovations across the NHS. It operates an ecosystem spanning leading NHS trusts, universities (UCL, Queen Mary), and specialist hospitals, delivering services including clinical innovation creation, NHS implementation support, healthcare transformation, futures thinking, patient safety programmes, and evaluation/insights. It also develops and supports digital health tools such as the Proactive Care Frameworks, Living With Covid Recovery, and AI-enabled dementia apps.

Product overview

UCLPartners is a health innovation company offering a portfolio of frameworks, digital tools, and programmes rather than a single unified product. The core Proactive Care Frameworks provide systematic risk stratification and self-management support for six long-term conditions (Hypertension, Type 2 Diabetes, Cholesterol, Atrial Fibrillation, Asthma, COPD) with companion search tools for EMIS and SystmOne systems. Supporting digital products include the Living With Covid Recovery rehabilitation app and AI-enabled dementia tools (PuntoTest and PuntoCare). The Bedside Learning Coordinator app, developed with Telesoftas, enables frontline insight capture. Innovation support programmes include the NHS Innovation Accelerator and Innovation Fellowship. The company also operates partnerships such as the Alzheimer's Society collaboration and Climate Collaborative.

Differentiator

Problem solved

Functional benefit

Products and services

• Proactive Care Frameworks Comprehensive framework with systematic risk stratification tools and self-management resources covering six long-term conditions (Hypertension, Type 2 Diabetes, Cholesterol, Atrial Fibrillation, Asthma, COPD). Includes automated searches for EMIS and SystmOne, prioritisation protocols, and workforce deployment guidance for NHS primary care.
• Living With Covid Recovery Digital rehabilitation tool targeting Long COVID symptoms (fatigue, anxiety, breathing problems), combining evidence-based methods from physiotherapists, psychologists, dieticians and respiratory physicians to create bespoke treatment plans. Includes a patient app and clinical dashboard, deployed across NHS trusts.
• PuntoTest AI-enabled clinical app for faster, scalable detection of mild cognitive impairment and dementia, supporting earlier and more appropriate referrals across primary care and memory service pathways.
• PuntoCare AI-powered app providing personalised post-diagnostic support for patients and carers living with dementia, delivered through NHS memory services.
• Bedside Learning Coordinator App Web-based app developed with Telesoftas for frontline NHS staff insight capture, enabling Bedside Learning Coordinators to enter insights directly into a database and track action progress on improvement suggestions.

Quantifiable outcome

• £65.7M raised into local health tech ecosystem
• +5 more outcomes

Named customers8 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability12 records

Feature4 records

Partnerships

17 partnerships are on record, tiered core and secondary.

• Punto HealthcoreStrategic or Co-development Partner · 1 March 2026Collaboration on two NIHR i4i FAST Awards for PuntoTest and PuntoCare AI-enabled apps for dementia diagnosis and care. UCLPartners co-developed NIHR bids, leads health economic evaluation and PPIE activity.
• Alzheimer's SocietycoreStrategic or Co-development Partner · 1 March 2026Partnership to support innovators in Alzheimer's Society's Launchpad and Accelerator programmes, providing practical insight into NHS navigation and mentoring support.
• Oxleas NHS Foundation TrustsecondaryStrategic or Co-development Partner · 1 March 2026Partner in dementia AI app trials, delivering multi-site feasibility study of PuntoCare in NHS memory services.
• North London NHS Foundation TrustsecondaryStrategic or Co-development Partner · 1 March 2026Partner in dementia AI app trials alongside Oxleas and UCLPartners.
• Google DeepMindcoreStrategic or Co-development Partner · 1 February 2026New Chair Dorothy Chou serves as Director of Public Engagement at Google DeepMind. Her focus on ensuring technology delivers real public value aligns with UCLPartners mission.
• Association of AnaesthetistssecondaryStrategic or Co-development Partner · 1 October 2025Collaboration on clinician-led AI initiative for anaesthesia, perioperative medicine, and pain management. Identifies highest-priority clinical challenges where AI could make measurable difference.
• Health NavigatorcoreStrategic or Co-development Partner · 1 December 2024Three-year AI initiative for North East London providing preventative care through advanced AI screening and clinical coaching. Supported by largest RCT to date on AI-assisted preventative care.
• Macmillan Cancer SupportsecondaryStrategic or Co-development Partner · 1 September 2021Partnership to increase access to personalised holistic support for people diagnosed with cancer, including financial, emotional and practical needs.
• Barts Health NHS TrustcoreStrategic or Co-development PartnerFounding partner and founding member of UCLPartners. Collaborates on multiple innovation programmes including AI initiatives, cholesterol testing, and clinical transformation projects. Group CEO Shane DeGaris serves as Interim Chair of UCLPartners.
• UCL (University College London)coreStrategic or Co-development PartnerKey academic partner providing research expertise and innovation capabilities. Home to UCL Institute of Healthcare Engineering and Dementia Research Institute.
• NHS EnglandcoreStrategic or Co-development PartnerCommissioning partner for national programmes including NHS 111 Mental Health evaluation, NHS Innovation Accelerator, and Blood Pressure Optimisation Programme.
• Health Innovation NetworkcoreStrategic or Co-development PartnerPart of the national Health Innovation Network (AHSN Network) consisting of 15 Academic Health Science Networks across England, implementing national health innovation programmes.
• TelesoftassecondaryTechnology or IntegrationTechnology partner for development of the Bedside Learning Coordinator web-based app to streamline data flows for capturing staff insights.
• Living WithcoreStrategic or Co-development PartnerHealth-tech partner for Living With Covid Recovery digital rehabilitation programme, developing app and dashboard for remote patient support.
• NIHR (National Institute for Health and Care Research)coreStrategic or Co-development PartnerFunder of multiple innovation programmes including NIHR i4i FAST Awards for Punto Health dementia apps and Living With Covid Recovery (£780k+).
• Health Innovation Network South LondonsecondaryChannel Partner/ Reseller/ DistributorCollaborating partner on NHS 111 Mental Health evaluation in London.
• NHS North East LondoncoreStrategic or Co-development PartnerICS partner for AI initiative to transform urgent and emergency care through predictive, proactive and preventive care.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Imperial College Health Partners: London-based AHSN/AHSP bringing together Imperial College with Chelsea and Westminster, Imperial College Healthcare and other NW London trusts. Directly comparable academic-NHS innovation intermediary serving overlapping NHS and academic footprint.
• Cambridge University Health Partners: Academic Health Science Partnership combining Cambridge University Hospitals, Cambridge and Peterborough NHS Foundation Trust, the University of Cambridge and Papworth. Closely analogous AMC + university innovation intermediary in the East of England.
• North West Coast Academic Health Science Network: AHSN covering Cheshire, Merseyside, Lancashire and South Cumbria with overlapping Innovation Accelerator, patient safety and industry partnership programmes. Direct peer in the same 15-AHSN network.
• King's Health Partners: Academic Health Science Centre combining King's College London with Guy's & St Thomas', King's College Hospital and South London and Maudsley NHS trusts. Mirrors UCLPartners' model of bridging an AMC + university + NHS ecosystem to translate research into clinical practice across South London.
• Health Innovation Manchester: AHSN covering Greater Manchester with a near-identical mandate to broker health innovation across NHS trusts, universities and industry. Operates comparable programmes in cardiovascular disease, AI urgent care and Innovation Accelerator hosting.
• West Midlands Academic Health Science Network: Regional AHSN delivering NHS innovation adoption across the West Midlands with comparable Meridian and Innovation Exchange programmes. Operating partner within the same national AHSN framework as UCLPartners.
• Yorkshire & Humber Academic Health Science Network: Regional AHSN with a parallel NHS innovation brokering mandate across Yorkshire and the Humber. Sister organisation within the Health Innovation Network with similar programme categories and NIHR/NHS England funder relationships.
• Oxford Academic Health Science Network: AHSN covering Oxfordshire and surrounding regions, hosting patient safety, digital health and innovation adoption programmes. Direct peer within the national 15-AHSN network of which UCLPartners is itself a member.

Others

• Health Foundation: Independent UK health improvement charity funding innovation and improvement programmes across the NHS. Acts more as a complementary grant-maker than competitor, addressing adjacent improvement priorities.
• NIHR (National Institute for Health and Care Research): Primary funder of UK health and care research, including the i4i FAST Awards that finance UCLPartners-led dementia and COVID recovery programmes. Functions as a major upstream funding counterparty, not a competitive peer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/uclpartners
• LinkedInlinkedin.com/company/1224256

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about UCLParnters